Sakaura Hironobu, Hosono Noboru, Mukai Yoshihiro, Ishii Takahiro, Yonenobu Kazuo, Yoshikawa Hideki
Department of Orthopedic Surgery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
J Spinal Disord Tech. 2004 Aug;17(4):297-300. doi: 10.1097/01.bsd.0000096269.75373.9b.
Total en bloc spondylectomy (TES) was devised to minimize the incidence of local recurrence following resection of spinal tumor. Successful local control with TES has been reported for patients with primary malignant or aggressive benign spinal tumors. As for metastatic spinal tumors, however, only a few surgeons except for the inventor group have reported the outcome of TES. The purpose of this study was to investigate whether TES could provide radical resection of the tumor in patients with solitary spinal metastases.
Twelve patients underwent TES for a solitary metastatic tumor of the thoracolumbar spine. Primary malignancies included breast cancer in four patients, thyroid cancer in three, renal cell carcinoma in three, lung cancer in one, and unknown in one. All patients were regularly followed up with plain radiographs, computed tomography scans, and magnetic resonance imaging to detect local recurrence.
In two of the four cases with paraspinal tumor extension, local recurrences developed at 25 months after surgery. Seven patients have survived for an average of 61 months, while the remaining five died of disseminated metastases with a mean survival of 23 months after surgery. Local recurrences were common in patients with paraspinal extensions. TES for lesions with paraspinal extensions failed to provide curative resection of the tumor.
Given the great technical demands and potential risks of TES, the indication for TES with spinal metastases should be limited to cases with solitary lesions that do not extend to the paraspinal area.
全椎体整块切除术(TES)旨在尽量降低脊柱肿瘤切除术后局部复发的发生率。对于原发性恶性或侵袭性良性脊柱肿瘤患者,已有采用TES实现成功局部控制的报道。然而,对于转移性脊柱肿瘤,除发明者团队外,仅有少数外科医生报道了TES的治疗结果。本研究的目的是调查TES能否为孤立性脊柱转移瘤患者提供肿瘤的根治性切除。
12例患者因胸腰椎孤立性转移瘤接受了TES。原发性恶性肿瘤包括4例乳腺癌、3例甲状腺癌、3例肾细胞癌、1例肺癌和1例原发灶不明者。所有患者均定期接受X线平片、计算机断层扫描和磁共振成像检查以检测局部复发情况。
在4例伴有椎旁肿瘤扩展的病例中,有2例在术后25个月出现局部复发。7例患者存活,平均存活时间为61个月,其余5例死于播散性转移,术后平均生存23个月。椎旁扩展的患者中局部复发很常见。对伴有椎旁扩展的病变行TES未能实现肿瘤的根治性切除。
鉴于TES对技术要求高且存在潜在风险,脊柱转移瘤行TES的适应证应仅限于不累及椎旁区域的孤立性病变病例。